Piramal Enterprises has been on an acquisition spree and the company's COO said that there is no cash constraint for acquisitions.

Note ban impact on realty not as bad as projected: Ajay Piramal

Asserting that sales in A-class real estate sector have been about 75 percent of the average, Ajay Piramal of Piramal Enterprises rubbished concerns of demonetisation have a big impact on realty.

Demerger of pharma, financial srvs biz to take 2 years: Piramal

In next two years, the company plans to grow both organically and via acquisitions in its financial services, pharmaceutical and information management business, says Ajay Piramal, Chairman of the Piramal Group.

NCL Industries exits CDR; plans to expand cement business

K Ravi, Managing Director, NCL Industries says cement prices are very encouraging and the company plans to expand its cement business.

'Will look at Lafarge only if it makes strategic sense'

In a special chat with CNBC-TV18‘s Shereen Bhan, Ajay Piramal, Chairman, Piramal Enterprises said it was yet too early to comment on whether they would be acquiring Lafarge's India cement business.

Aim to be among top 3 cos in OTC drugs: Piramal Enterprises

Kedar Rajadnye, COO -Consumer Products Division, indicated that the company, which has grown at 18 percent in last 4-5 years, is in line to achieve its Rs 1,000 crore revenue target by 2020.

Baby care brand will add 8-10% to topline growth: Piramal

Piramal Enterprise‘s consumer product division has acquired the baby care brand Little‘s for Rs 73 crore.

Piramal, Canada's CPPIB form $500mn realty investment fund

Piramal and CPPIB will initially invest USD 250 million each in the venture, which will focus on providing project-level debt to local developers across Mumbai, Delhi region, Bangalore, Pune and Chennai markets.

Strong growth in Indian telecom to continue: Ajay Piramal

Chairman of Piramal Healthcare, Ajay Piramal says that the Indian telecom story is still very positive and the growth is likely to continue.

Deal with Eli Lilly, Merck on track: Piramal Healthcare

Swati Piramal, director of Piramal Healthcare tells CNBC-TV18 that it is one of the few pharma companies which are pushing for drug discovery.

Exit guaranteed from Vodafone irrespective of IPO: Piramal

Piramal Healthcare has planned to picked up a 5.5% stake in Vodafone-Essar, valued at about USD 640 million. CNBC-TV18's executive editor Shereen Bhan spoke to chairman of the company, Ajay Piramal on the transaction.

Piramal-Vodafone fair deal but core biz worries exist

In an interview to CNBC-TV18, Vikas Dandekar, India bureau chief of Pharmasianews, says the Pirmal-Vodafone deal is a smart move but the question remains on what happens to the core business. However, he says, over a longer period of time there will be some value accretion.

Piramal Healthcare to buy Oxygen Healthcare: PharmaAsia

Piramal Healthcare is set to buy Ahmedabad-based Oxygen Healthcare, reports CNBC-TV18 quoting Pharma Asia News.